Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04338685
Title A Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications

skin melanoma

Advanced Solid Tumor

hepatocellular carcinoma

pancreatic ductal adenocarcinoma

biliary tract cancer

gallbladder cancer

renal cell carcinoma

triple-receptor negative breast cancer

fibrolamellar carcinoma

ocular melanoma

colorectal cancer

stomach cancer

Therapies

RO7119929 + Tocilizumab

Age Groups: senior | adult
Covered Countries USA | ESP


No variant requirements are available.